Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome

American Journal of Clinical Pathology

Volumn 124, Issue 4, 2005, Pages 543-549

  Preusser, Matthias ^a   Wolfsberger, Stefan ^b   Czech, Thomas ^b   Slavc, Irene ^b   Budka, Herbert ^a   Hainfellner, Johannes A ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Ependymoma; Prognosis; Proliferation; Survivin

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; KI 67 ANTIGEN; SURVIVIN;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CELL PROLIFERATION; CHILD; EPENDYMOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 25844453436     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/PP2G5GAAFKV82DTG     Document Type: Article

References (33)

1. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917-921.
2. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580-584.
3. Altieri DC. Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J Cell Biochem. 2004;92:656-663.
4. Adida C, Haioun C, Gaulard P, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 2000;96:1921-1925.
5. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer. 2003;88:115-119.
6. Kajiwara Y, Yamasaki F, Hama S, et al. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer. 2003;97:1077-1083.
7. Kami K, Doi R, Koizumi M, et al. Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery. 2004;136:443-448.
8. Kappler M, Kotzsch M, Bartel F, et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Ciin Cancer Res. 2003;9:1098-1104.
9. Martinez A, Bellosillo B, Bosch F, et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am J Pathol. 2004;164:501-510.
10. Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 2000;46:645-650.
11. Sarela AI, Scott N, Ramsdale J, et al. Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol. 2001;8:305-310.
12. Schlette EJ, Medeiros LJ, Goy A, et al. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncoi. 2004;22:1682-1688.
13. Span PN, Sweep FC, Wiegerinck ET, et al. Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin Chem. 2004;50:1986-1993.
14. Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer. Br J Cancer. 2003;88:1077-1083.
15. Okada E, Murai Y, Matsui K, et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 2001;163:109-116.
16. Trieb K, Lehner R, Stulnig T, et al. Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol. 2003;29:379-382.
17. Preusser M, Gelpi E, Matej R, et al. No prognostic impact of survivin expression in glioblastoma. Acta Neuropathol (Berl). 2005;109:534-538.
18. Altura RA, Olshefski RS, Jiang Y, et al. Nuclear expression of survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br J Cancer. 2003;89:1743-1749.
19. Wolfsberger S, Fischer I, Hoftberger R, et al. Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma. Am J Surg Pathol. 2004;28:914-920.
20. Kleihues P, Cavenee W, eds. Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC Press; 2000. World Health Organization Classification of Tumours.
21. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215-229.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1985;53:457-481.
23. Sasaki T, Lopes MB, Hankins GR, et al. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol (Berl). 2002;104:105-109.
24. Bredel M, Piribauer M, Marosi C, et al. High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients. Eur J Cancer. 2002;38:1343-1347.
25. Chiesa-Votcero AG, Rybicki LA, Prayson RA. Comparison of proliferation indices in glioblastoma multiforme by whole tissue section vs tissue microarray. Am J Clin Pathol. 2003;120:902-908.
26. Dictor M, Ehinger M, Mertens F, et al. Abnormal cell cycle regulation in malignancy. Am J Clin Pathol. 1999;112(1 suppl 1):S40-S52.
27. Ho DM, Hsu CY, Ting LT, et al. MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma. Am J Clin Pathol. 2003;119:715-722.
28. Hsu DW, Louis DN, Efird JT, et al. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas. J Neuropathol Exp Neurol. 1997;56:857-865.
29. Prayson RA. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases. Am J Clin Pathol. 1998;110:629-634.
30. Rickerc CH, Paulus W. Prognosis-related histomorphological and immunohisCochemical markers in central nervous system tumors of childhood and adolescence. Acta Neuropathol (Berl). 2005;109:69-92.
31. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715.
32. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311-322.
33. Agostinho M, Rino J, Braga J, et al. Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. Mol Biol Cell. 2004;15:2388-2400.